TL;DR
- GLP-1 is a hormone your gut releases after you eat. It helps your body release insulin in response to a meal and is one of the signals involved in feeling full.
- Studies in rats and in gut cells grown in the lab (Lu et al., 2009; Yu et al., 2010; Yu et al., 2015; Yue et al., 2018) reported that berberine increased GLP-1 release.
- We found no published human trial that measured GLP-1 levels after people took berberine. Human berberine trials have measured blood sugar markers instead (Liang et al., 2019).
- CraveHack contains 125 mg of berberine per serving — below the 1,000–1,500 mg per day used in human berberine trials, and far below the per-kilogram amounts given to rats.
- Berberine is a dietary supplement, not a substitute for any prescription medication. Anyone taking medication should talk to a healthcare provider before trying it.
The product in this guide: CraveHack — buy now →
"GLP-1" has become one of the most searched terms in health, and supplement marketing has followed. Berberine comes up again and again in those conversations, often with the suggestion that it raises GLP-1 in the body. This article looks at what the studies behind that idea actually tested, what they did not test, and how much berberine they used.
What is GLP-1?
GLP-1 (glucagon-like peptide-1) is a hormone made by L cells, specialized cells in the lining of the small and large intestine. When food reaches the gut, these cells release GLP-1 into the bloodstream. It helps the pancreas release insulin in proportion to the meal, slows how quickly the stomach empties, and is one of several signals the brain uses to register fullness. The body breaks it down within minutes, so its levels rise and fall around meals.
Because GLP-1 is a natural hormone, foods and nutrients that might nudge its release have drawn research interest. Fiber and protein are the best-known examples. Berberine is studied for a different reason: it is intensely bitter, and the gut has bitter taste receptors on the same cells that make GLP-1.

CraveHack
Ten ingredients incl. chromium, L-carnitine, green tea and berberine · 2 capsules a day · 30 servings
✓ Doctor formulated✓ Third-party tested✓ GMP certified✓ Made in USA
Get CraveHack →$49.99 · free US shipping over $75
What the berberine and GLP-1 studies actually tested
Studies in rats
Lu and colleagues (2009, Journal of Endocrinology) gave rats with chemically raised blood sugar 120 mg of berberine per kilogram of body mass every day for five weeks. After a glucose drink, the berberine group had higher GLP-1 levels in the blood and intestine than the control group, along with more GLP-1-producing L cells in the gut.
A follow-up by Yu and colleagues (2010, Biochemical Pharmacology) found the same pattern in healthy rats: five weeks of berberine raised the GLP-1 response to a glucose load and increased the activity of the gene that GLP-1 is made from. The same paper showed berberine increasing GLP-1 release from human gut cells grown in the lab, in a dose-dependent way.
Studies in gut cells
Two later studies looked at why. Yu and colleagues (2015, Biochemical Pharmacology) found that a bitter taste receptor called TAS2R38 sits on human GLP-1-producing cells, and that blocking or silencing that receptor reduced the GLP-1 release berberine triggered. Yue and colleagues (2018, Molecular and Cellular Biochemistry) reported a similar bitter-taste pathway in mouse gut cells.
Taken together, these studies describe a plausible mechanism: berberine's bitterness may be "tasted" by receptors in the gut, which then prompt GLP-1 release. That is a real and interesting finding. It is also a finding about rats and cells in a dish.
Has any human study measured GLP-1 after berberine?
Not that we could find. A PubMed search in October 2026 for berberine studies mentioning GLP-1 returned no clinical trials. The human berberine research that does exist has measured other outcomes. Yin, Xing, and Ye (2008, Metabolism) reported changes in blood sugar markers in adults over three months, and a meta-analysis by Liang and colleagues (2019, Endocrine Journal) pooled randomized trials in adults with elevated blood sugar markers. Neither measured GLP-1.
So the honest answer to the title question is: berberine raised GLP-1 release in rats and in lab-grown gut cells, and nobody has yet published a trial showing whether it does the same in people at the amounts found in supplements. Any product page that says berberine "raises GLP-1" in you is going beyond the evidence.
Why the amount matters
The rats in Lu and colleagues' study received 120 mg of berberine per kilogram of body mass per day. Human berberine trials have generally used 1,000–1,500 mg per day, split across meals. One serving of CraveHack contains 125 mg of berberine. For a 70 kg adult, that is under 2 mg per kilogram — a small fraction of what the rats received, and well below the human trial range.
Animal doses do not translate to people one-to-one, so this is not a precise comparison. But it is a reason not to read the rat findings as a prediction of what 125 mg will do.
A note on GLP-1-branded supplements
As GLP-1 became a household term, a wave of products began borrowing it. White and colleagues (2026, Annals of Pharmacotherapy) reviewed 24 transdermal patches and one gel sold as GLP-1-branded dietary supplements; berberine was among the most common ingredients. The authors noted that none posted certificates of analysis, and that dietary supplements under US law must be swallowed, which patches are not. It is a useful reminder to check what a product's label actually says and what its claims are based on.
Where CraveHack fits
CraveHack is a ten-ingredient formula from NutraHack Labs, and berberine is one of those ingredients. Its label describes it as Natural Appetite & Metabolism Support* that helps balance digestion, energy, and cravings.* No study has tested CraveHack's effect on GLP-1, and we do not claim one.
Per 2-capsule serving, CraveHack contains: Chromium (as Chromium Picolinate) 180 mcg (514% DV); L-Carnitine Tartrate 250 mg; Green Tea (Camellia sinensis) leaf extract 150 mg; Berberine HCl 125 mg; Turmeric (Curcuma longa) rhizome extract 50 mg; Grains of Paradise (Aframomum melegueta) seed extract 25 mg; Black Pepper (Piper nigrum) fruit extract (95% piperine) 5 mg; Cayenne Pepper (Capsicum annuum) fruit 5 mg; Probiotic Blend 125 mg (Bifidobacterium lactis, Lactobacillus plantarum, L. rhamnosus, L. gasseri, Akkermansia muciniphila); and Prebiotic Fiber Blend 100 mg (Organic Jerusalem Artichoke Root, Organic Acacia Senegal). The berberine in CraveHack is 125 mg per serving — below the 1,000–1,500 mg per day used in published berberine trials, and no trial has tested this combination. Label directions: take 2 capsules with water or as directed by a healthcare professional.
For more on berberine itself, see Berberine: What It Is, How It Works & What Research Shows, and for one of CraveHack's other ingredients, What Does Chromium Do in the Body?
Who should be cautious
Berberine can affect liver enzymes that process many prescription drugs, and it is studied for its effect on blood sugar markers. Anyone taking prescription medication — especially medication that affects blood sugar — should talk to a doctor or pharmacist before taking berberine. It is not recommended during pregnancy or while breastfeeding. The most common side effects in studies are digestive: upset stomach, constipation or loose stools.
Frequently Asked Questions
Does berberine raise GLP-1 in people?
It has not been shown. Berberine increased GLP-1 release in rat studies and in gut cells grown in the lab, but we found no published human trial that measured GLP-1 levels after people took berberine.
Is berberine a substitute for prescription medication?
No. Berberine is a dietary supplement and is not a substitute for any prescription medication. Don't stop or change a prescribed medication without talking to the clinician who prescribed it.
How much berberine is in CraveHack?
125 mg of Berberine HCl per 2-capsule serving. That is below the 1,000–1,500 mg per day used in human berberine trials.
Why would a bitter compound affect a gut hormone?
The cells in the gut that make GLP-1 carry bitter taste receptors. In lab studies (Yu et al., 2015; Yue et al., 2018), blocking one of those receptors, TAS2R38, reduced the GLP-1 release that berberine triggered. Whether this matters at supplement amounts in people has not been tested.
If you'd like to see the full ingredient panel and label directions, visit the CraveHack product page — and check with your healthcare provider before adding anything new, especially if you take medication.

CraveHack
Ten ingredients incl. chromium, L-carnitine, green tea and berberine · 2 capsules a day · 30 servings
✓ Doctor formulated✓ Third-party tested✓ GMP certified✓ Made in USA
Get CraveHack →$49.99 · free US shipping over $75
Studies mentioned
- Lu et al., 2009, Journal of Endocrinology, doi:10.1677/JOE-08-0419 — five weeks of berberine in rats with chemically raised blood sugar; measured GLP-1 in blood and intestine.
- Yu et al., 2010, Biochemical Pharmacology, doi:10.1016/j.bcp.2009.11.017 — berberine and GLP-1 release in healthy rats and in human gut cells grown in the lab.
- Yu et al., 2015, Biochemical Pharmacology, doi:10.1016/j.bcp.2015.07.012 — the TAS2R38 bitter taste receptor and berberine-triggered GLP-1 release in human gut cells.
- Yue et al., 2018, Molecular and Cellular Biochemistry, doi:10.1007/s11010-018-3290-3 — bitter-taste signaling and GLP-1 release in mouse gut cells.
- Yin et al., 2008, Metabolism, doi:10.1016/j.metabol.2008.01.013 — three-month human study of berberine and blood sugar markers.
- Liang et al., 2019, Endocrine Journal, doi:10.1507/endocrj.EJ18-0109 — meta-analysis of randomized berberine trials in adults with elevated blood sugar markers.
- White et al., 2026, Annals of Pharmacotherapy, doi:10.1177/10600280251407145 — review of transdermal products sold as GLP-1-branded supplements.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.